The effect of novel antipsychotics in rat oral dyskinesia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 23, Issue 8, 1999, Pages 1389-1404

  Rosengarten, Helen ^a   Schweitzer, Jack W ^a   Friedhoff, Arnold J ^a  

^a NEW YORK UNIVERSITY   (United States)

Author keywords

5HT 2(C) receptor mediated oral behavior; D 1 receptor mediated oral behavior

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CLOZAPINE; MIANSERIN; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SEROTONIN 2C AGONIST; SEROTONIN 2C ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG INHIBITION; DRUG MECHANISM; DYSKINESIA; INTRAPERITONEAL DRUG ADMINISTRATION; JAW MOVEMENT; MALE; NONHUMAN; RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIAS; JAW; MALE; MOVEMENT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN;

EID: 0033231486     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(99)00073-1     Document Type: Article

References (60)

1. Anand V.S. and Dewan M.I. (1996) Withdrawal emergent dyskinesia in a patient on risperdal undergoing dosage reduction. Ann. of Clin.Psych. 8, 179-182.
2. Andreassen O.A. and Jorgensen, H.A. (1995) The rat model of tardive dyskinesia:relationship between vacuous chewing movements and gross motor activity during acute and long-term haloperidol treatment. Life sci. 57, 2263-2272
3. Bedard, P, Larochelle, L., Delean, I. and Lafleur, I. (1972) Dyskinesias induced by long-term administration of haloperidol in the monkey. Physiologist 15, 83-83
4. Bedard, P. D1 receptors in neurology and psychiatry an overview (1995) Progress in Neuro-Psychopharm. and Biol Psych. 19, 713-726.
5. Beasley, C.M., Sanger, T., Saterlee, W., Tollefson, G., Tran, P., and Hamilton, S. (1996) Olanzapine versus placebo: results in double blind study, fixed dose olanzapine trial. Psychopharmacology 124: 159-167
6. Borison, R.L. (1995) Clinical efficacy of serotonin-dopamine antagonists relative to classical neuroleptics. J.of Clin. Psychopharm. 15: (1), 24s-29s.
7. Briggs, C.A., Pollock, N.J., Frail, D.E., Paxson, C.L., Rakowski, R., Kang, C.H. and Kebabian, J.W. (1991) Activation of the 5HT-1C receptor expressed in xenopus oocytes by the benzazepine SCH 23390 and SKF 38393. Brit. J. of Psychopharm. 104: 1038-1044
8. Brus, R., Kostrzewa, R.M., Perry, and K.W., Fuller. R.W. (1994) Supersensitization of oral response to SKF38393 in neonatal 6-hydroxydopamine - lesioned rats is eliminated by neonatal 5,7-dihydroxytryptamine treatment. J. Pharmacol. Exp. Ther. 268: 231-237
9. Buzan R.D. (1996) Risperdal induced tardive dyskinesia. Am.J. Psychiatry, 153: 734-735
10. 1-adrenergic and muscarinic receptors in vivo in rats. 124: 87-94.
11. Casey, D.E. (1984) Tardive dyskinesia-animal models. Psychopharm. Bull.20 376-379
12. Casey, D.E. (1996) Side effects profiles of new antipsychotic agents. J. Clin. Psychiatry. 57: 40-52
13. Chouinard, G., Jones, B., Remington, G., Bloom, D., McEwan G.W., Labelle, A., and Beauclair (1993) Canadian multicenter placebo controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J. Clin. Psychopharmacol. 13, 25-40
14. Civelli, O., Bunzow, J.R., Zhow, Q and Grandy, D.K. (1992) The diversity of dopamine receptors. NIDA Res.Monogr. 126: 23-33
15. Clow, A., Jenner, P., and Marsden, C.D. (1979) Changes in dopamine mediated behavior during one year's neuroleptic administration. Eur.J. Pharmacol. 57: 363-364
16. Collins, P., Broenkamp, C.L., Jenner, P. and Marsden, C.D. (1991) Drugs acting at D1 and D2 dopamine receptors induce identical purposeless chewing in rats which can be differentiated by cholinergic manipulation. Psychopharmacology: 103 (94): 503-512
17. Eberle-Wang, K., Lucki, I. and Chesselet, M.F. (1996) A role for subthalamic nucleus in 5HT2C-induced oral dyskinesia. Neuroscience 72: 117-128
18. Egan, M.F., Ferguson, H.Y., Bachus, S.E., Hamid, E.H. and Hyde, T.M.(1996) Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol. Psychopharmacology 127: 337-345
19. Ellison, G. and See, R.E. (1989) Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia. Psychopharmacology, 98: 564-566
20. Glenthoj, B. (1993) Persistent vacuous chewing in rats following neuroleptic treatment in relation to dopaminergic and cholinergic function. Psychopharmacology. 113 (2). 157-166
21. Gong, L., and Kostrzewa, R.M. (1991) Supersensitized oral responses to a serotonin agonist in neonatal 6 - OHDA treated rats. Pharmacol. Biochem. Beh. 41: 621-623
22. Gong, U., Kostrzewa, R.M., Fuller, R.W. and Perry, K.W. (1992) Supersensitization of the oral response to SKF38393 in neonatal 6-OHDA- lesioned rats is mediated through a serotonin system. The J. Pharmacol.Exp.Ther. 261, 1000-1007.
23. Hamblin, M.E. and Creese, I. (1983) Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N - ethoxycarbonyl-1-2 - ethoxy -1,2, dihydroquinoline. Life Sci. 32: 2247-2255
24. Kakigi, T., Gao, X.M. and Tamminga C.A.(1995) Drug induced dyskinesia in rats after traditional and neuroleptics. J. Neural.Transm. 101: 41-49
25. Kebabian, J.W. and Calne, D.B. (1979) Multiple receptors for dopamine. Nature.277: 243-250
26. Kinon, B.J. and Lieberman, J.A. (1996) Mechanism of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology 124: 2-34
27. Koshikawa, N., Aoki, S., Tomiyama, K., Kobayashi, M., Tsuboi, Y., Iwata, K., Sumino, R. and Stephenson, R.D. (1989) Effects of intrastriatal injection of selective dopamine D1 and D2 agonists and antagonists on jaw movements in rats. Eur. J. Pharmacol. 163, 227-236
28. Kostrzewa, R.M., Gong, I., and Brus, R. (1993) Serotonin (5-HT) systems mediate dopamine (DA) receptor supersensitivity. Acta Neurobiologiae Experimentalis 53: 31-41.
29. Lublin H. and Gerlach, J. (1988) Behavioral effects of dopamine D1 and D2 receptor agonist in monkey persistently treated with haloperidol. Eur.J.Pharmacol. 153: 229-245
30. Marder, S.R. and Meibach, R.C. (1994) Risperidone in the treatment of schizophrenia. Am. J. Psychiatry. 151, 825-835
31. Meltzer, H. (1995) The role of serotonin in schizophrenia and the place of serotonin-dopamine antagonist antipsychotics; J. of Clin. Psychopharmacol. 15: suppl. 1, 2s-3s, 1995
32. Molloy, A.G. and Waddington, J.L. (1984) Dopaminergic behavior stereospecifically promoted by the D-1 Agonist R-SK&F 38393 and selectively blocked by the D-1 antagonist SCH23390. Psychopharmacology 92: 164-168
33. Moore, N.A., Leonder, J.D., Benvengu, M.J., Gleason, S.D., Shennon, H. (1992) Behavioral pharmacology of olanzapine: a novel antipsychotic drug. J.Clin.Psych.58 suppl 10, 37-44
34. Murray, A.M. and Waddington, J.L. (1989) The induction of grooming and vacuous chewing by a series of selective D-1 dopamine agonists: two directions of D-1:D-2 interaction. Eur.J.Pharmacol. 186: 49-59
35. Peacock, L., Lublin, H., and Gerlach, J. (1990) The effects of dopamine D1 and D2 receptor agonist and antagonists in monkey withdrawn from long-term neuroleptic treatment. Eur. J. Pharmacol. 160: 377-384
36. Pilovsky, L.S., Busatto, G.F., Taylor, M., Costa, D.C., Sharma, T., Sigmundson, T., Ell, P.J., Nohria, V. and Kervin, R.W. (1996) Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine- a 1231 Ibmz single photon emission tomography (SPET) study. Psychopharmacol. 124: 148-153
37. Plech, A., Brus, R., Kalbfleish, J.HG. and Kostrzewa, R.M. (1995) Enhanced oral activity in response to intrastriatal SKF38393 and m-CPP are attenuated by mianserine in neonatal 6 - OHDA lesioned rats. Psychopharmacol. 119, 466-473
38. Rosengarten, H., Schweitzer, J.W., and Friedhoff, J. A.(1983) Induction of oral dyskinesia in naive rats by D1 stimulation. Life Sci. 33: 2479-2482.
39. Rosengarten, H., Schweitzer, J.W., Egawa, M. and Friedhoff J.A. (1986) Diminished dopamine receptor function and the emergence of repetitive jaw movements. Adv. Exp. Med. Biol. 235: 159-167
40. Rosengarten, H., Schweitz ER, J.W. and Friedhoff, A.J. (1987) Prolonged fluphenazine decanoate treatment augments oral movements in rats: mediation by D1 receptors. Sixth Catecholamine Symposium Abstract 14.
41. Rosengarten, H., Schweitzer, J.W. and Friedhoff, A.J. (1989) A full repetitive jaw movements response after 70% depletion of caudate D1 receptors. Pharmacol. Biochem. Beh 34: 895-897
42. Rosengarten, H. and Friedhoff, A.J. (1998) A phosphoinositide - linked D1dopamine receptor mediates repetitive jaw movements in rats. Biol.Psychiatry. 44: 1178-1184
43. Rupniak, N.M. , Jenner, P. and Marsden, C.D. (1985) Pharmacological characterization of spontaneous or drug associated purposeless chewing movements in rats. Psychopharmacology, 85: 71-79
44. Salamone, J.D. Johnson, C.J., McCullough, L.D. and Steinpreiss, R.E. (1990) Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat. Psychopharmacol. 102, 529-534
45. Scheel-Kruger, J. (1994) Neurotransmitter interactions in striatum mediating oral dyskinesia and stereotypies. Behav. Pharmacol. 5: 10
46. Schotte, A., Janssen, P.E.M., Gommeren, W., Luyten, W.H.M.L., Van Gompel, P. Lesage A.S., De Loore, K. and Leysen, J.E. (1993) Risperdal compared with new and reference antipsychotic drugs in vitro receptor binding. Psychopharmacol. 124: 57-73
47. Schotte A., Janssen, P.F., Megens, A.A. and Leysen, J.E. (1993) Occupancy of central neurotransmitter receptor by risperdal, clozapine and haloperidol measured ex vivo by quantitative autoradiography. Brain Res. 631: 191-202
48. Simpson, G.M. and Lindenmayer, J.P. (1997) Extrapyramidal symptoms in patients treated with risperidone. J. Clin. Psychopharmacol. 17: 194-201
49. Stewart, B.R., Jenner, P. and Marsden, C.D. (1989) Induction of purposeless chewing behavior in rats by 5HT agonist drugs. Eur. J. Pharmacol. 162: 101-107
50. Stoof, J.C. and Kebabian, J.W. (1981) Opposing roles for the D1 and D2 dopamine receptors. Nature, 294: 366-368
51. Sumiyoshi, T., Suzuki, K. Sakamoto, H., Yamagushi, N., Mori, H., Shiba, K. and Yokogawa, K. (1995) Atypicality of several antipsychotics on the basis of in vivo dopamine D2 and serotonin - 5HT2 receptor occupancy. Neuropsychopharmacology. 12: 57-64
52. Sumiyoshi, T., Kido, H, Sakamoto, H., Urasaki, K., Suzuki, K., Yamagushi, N., Mori, K., Shiba, K. and Yokogawa, K. (1994) In vivo dopamine D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol. Pharmacol. Biochem.Beh. 47: 553-557
53. Tamminga, C.A., Dale, J.M., Goodman, L., Kaneda, H. and Kaneda, N. (1990) Neuroleptic induced vacuous chewing movements as an animal model of tardive dyskinesia. Psychopharmacology 102: 474-478
54. Tran, P.V., Hamilton, S.H., Kuntz, A.J., Potvin, J.H., Anderson, S.W., Beasley, C. and Tollefson, G.D.(1997) double-blind comparison of olanzapine versus risperdal in the treatment of schizophrenia and other psychotic disorders. J. Clin. Psychopharmacol. 17: 407-418
55. Trevitt, J.T., Lyons, M., Aberman, J. Cariello, D. Finn, M. and Salamone, D.J. (1997) Effect of clozapine, thioridazine, risperdal and haloperidol in behavioral tests related to extrapyramidal motor function. Psychopharmacol. 132, 74-81
56. Trevitt, J. Akherton, A., Aberman, J. and Salamone, J.D. (1998) Effects of subchronic administration of clozapine, thioridazine and haloperidol in behavioral tests related to extrapyramidal motor function in the rat. Psychopharmacol. 137, 961-966
57. Undie, A.S., Weinstein, J., Sarau, H.M. and Friedman, E. (1994) Evidence for a distinctD1 - like dopamine receptor that couples to activation of phosphoinositide metabolism in the brain.J. Neurochem. 62: 2045-2048
58. Waddington, J.L. and Gamble, S.T. (1980) Neuroleptic treatment for a substantial proportion of adult life: behavioral sequelae of nine months haloperidol administration. 67: 363-364
59. Waddington, John, L. Siobhan, A. Daly, Ronald, P. Downes Aaron, M. Deveney, Patrick. G. McCauly and Kathy, M. O'bole (1995) Behavioral pharmacology of D-1 like dopamine receptors: further subtyping, new pharmacological probes and interactions with D-2 like receptors. Prog. Neuro-Psychopharmacol. & Biol. Psychiat. 19, 811-830
60. Woodward, R.M., Panicker, M.M., Miledi, R. (1992) Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in xenopus oocytes. Proc. Natl. Acad. Sci. 89: 4708-4712.